Eilean Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A First-in-Human Study of ZE66-0205 in Healthy Volunteers (NCT07735728) | Eilean Therapeutics | 2026-08-15 |
| Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers (NCT07529951) | Eilean Therapeutics | 2026-05-15 |
| Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients. (NCT07234864) | Eilean Therapeutics | 2025-11-19 |
| Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers (NCT06780124) | Eilean Therapeutics | 2024-04-12 |
Track Eilean Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.